SCHEMBL7869896

SCHEMBL7869896

O=C(O)c1ccc2cccoc1-2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACMSD Q8TDX5 3/20 0.44
HNF4A P41235 2/20 0.44
KEAP1 Q14145 1/20 0.43
PTPN1 P18031 3/20 0.41
DHFR P00374 1/20 0.40
MCL1 Q07820 1/20 0.40
CDC25B P30305 1/20 0.40
ATM Q13315 1/20 0.40
DCLRE1A Q6PJP8 1/20 0.40
DCLRE1B Q9H816 1/20 0.40
ALDH1A1 P00352 2/20 0.39
ALOX15 P16050 1/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 2/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 1/20 0.39
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
UCHL5 Q9Y5K5 1/20 0.39
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27624326 0.86 ACMSD (0.47) ACMSDHNF4APTPN1DHFRMCL1
SCHEMBL14901086 0.86 ALDH1A1 (0.46) ACMSDHNF4APTPN1DHFRMCL1
SCHEMBL27355083 0.82 ADORA2A (0.42) PTPN1ATMALDH1A1POLBKDM4E
Water SCHEMBL27300806 0.81 ADORA2A (0.41) PTPN1ALDH1A1POLBKDM4EHPGD
SCHEMBL15008652 0.77 RXFP1 (0.42) PTPN1MCL1ALDH1A1POLBKDM4E
SCHEMBL9256829 0.77 TP53 (0.50) MCL1ALDH1A1POLBKDM4EHPGD
SCHEMBL26119158 0.77 BCL2L1 (0.47) ACMSDKEAP1DHFRALDH1A1CYP1A2
SCHEMBL29375373 0.74 POLB (0.46) KEAP1PTPN1ALDH1A1ALOX15POLB
SCHEMBL27605296 0.74 ACMSD (0.53) ACMSDHNF4APTPN1DHFRMCL1
SCHEMBL21555682 0.73 KMT2A (0.44) ALDH1A1ALOX15CYP1A2POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108976186-A A method of the four substituted furan class compound of preparation based on carbon-hydrogen link activation 中国科学院大连化学物理研究所 2018-12-11 CN disclosed
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US disclosed
WO-2000051608-A1 3-THIENYL AND 3-FURANYL PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-09-08 WO disclosed
EP-0784620-B1 N-SUBSTITUTED PIPERIDINYL BICYCLIC BENZOATE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 1999-12-08 EP disclosed
EP-0784619-B1 PHENYL-OXO-ALKYL-(4-PIPERIDINYL)BENZOATE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 1999-03-24 EP disclosed
US-5872131-A Phenyl-oxo-alkyl-(4-piperidinyl)benzoate derivatives JANSSEN PHARMACEUTICA, N.V. (BE) 1999-02-16 US disclosed
EP-0784619-A1 PHENYL-OXO-ALKYL-(4-PIPERIDINYL)BENZOATE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1997-07-23 EP disclosed
EP-0784620-A1 N-SUBSTITUTED PIPERIDINYL BICYCLIC BENZOATE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1997-07-23 EP disclosed
WO-1996010026-A1 PHENYL-OXO-ALKYL-(4-PIPERIDINYL)BENZOATE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1996-04-04 WO disclosed
WO-1996010027-A1 N-SUBSTITUTED PIPERIDINYL BICYCLIC BENZOATE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1996-04-04 WO disclosed